InvestorsHub Logo
Followers 78
Posts 3789
Boards Moderated 0
Alias Born 12/21/2008

Re: None

Wednesday, 06/30/2010 4:58:06 PM

Wednesday, June 30, 2010 4:58:06 PM

Post# of 77519
I know I am beating this to death but I keep coming up with connections from the past to now..and am just throwing it out there..
Ok the good doctor mentioned in the last post was also a part founder of Biogen Idec right. ok well if you look at biogen website pipeline they have "Humanized monoclonal antibody specific for CD20. Humanized anti-CD20 mAb is being developed under a collaboration agreement with Genentech, a wholly-owned member of the Roche Group."
in the pipeline along with another.. OK but then you go back to
16 January 2006 and you find that our good friends at Favrille
was on a fast track with none other than TA-DA Genentech/Biogen Idec/Roche's Rituxan
http://www.thepharmaletter.com/file/83997/fda-fast-tracks-favrilles-favid.html
So now I am back to the "SUPER GLUE" I am trying to find information on that deal.. I mean Super Glue is great stuff and I use it all the time. And yes I know it is an example.. But who did this come from??
What research lab was able to find the key to bind the Specifid or what ever they are calling now. There is a Key here that if we are able to piece it together in a logical manner will help us understand how important this could be not only to the pps which is fine but to the good of people who are waiting in line to get rid of a dreaded disease. No matter what the pps is the important thing is to find the answers to help others...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.